RNA vaccines

Pfizer-BioNTech COVID-19 vaccine gains full US regulatory approval

The U.S. drug regulator on Aug. 23 granted full approval to the Pfizer Inc/BioNTech SE COVID-19 vaccine - the first to secure such Food and Drug Administration validation - prompting President Joe Biden to make a fresh pitch to vaccine skeptics to get the shot to fight the relentless pandemic.


Israel, US, France and Germany Launch Booster Campaigns as Covid-19 Surges again

A third dose of Pfizer Covid-19 vaccine has significantly improved protection from infection and serious illness among people aged 60 and older in Israel compared with those who received two shots, according to findings published by the Health Ministry and cited by Reuters. The full details of the study were not released.

Turkey joins EU COVID pass system

The European Union will accept Turkish COVID-19 certificates as of Aug. 20, the European Commission announced on on Aug. 19. 


The EU executive body adopted equivalence decisions for the COVID-19 certificates issued by the authorities of Turkey, North Macedonia, and Ukraine.

15,260 people vaccinated against COVID in last 24 hours

As many as 15,260 vaccine doses from Pfizer, Moderna, AstraZeneca and Johnson&Johnson were administered in the last 24 hours, of which 10,831 represent the first dose, and 4,429 the second dose, according to a briefing sent on Wednesday by Romania's National COVID-19 Vaccination Coordination Committee (CNCAV).

Study in Israel: Pfizer Vaccine only 39% Effective at Preventing Infection with Delta Variant

Over the past month, Israel, the world's most heavily vaccinated country (with leading mRNA jabs, no less) has seen the number of positive COVID tests has risen by more than 30x as the number of active infections in the country has surpassed 10,000.